Clinical trials
Heart Diseases trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
79 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2018 | 9 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 7 |
| 2025 | 8 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Recruiting | 19 |
| Active, not recruiting | 8 |
| Terminated | 7 |
| Unknown status | 5 |
| Not yet recruiting | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Scientific Corporation | 4 |
| Fundación EPIC | 3 |
| Medtronic Cardiac Rhythm and Heart Failure | 3 |
| OrbusNeich | 3 |
| P+F Products + Features GmbH | 3 |
| Abbott Medical Devices | 2 |
| Alexion Pharmaceuticals, Inc. | 2 |
| AstraZeneca | 2 |
| Cardurion Pharmaceuticals, Inc. | 2 |
| Cytori Therapeutics | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Diseases | 79 |
| Cardiovascular Diseases | 30 |
| Heart Failure | 12 |
| Coronary Artery Disease | 11 |
| Coronary Disease | 9 |
| Myocardial Infarction | 9 |
| Myocardial Ischemia | 9 |
| Atrial Fibrillation | 8 |
| Cardiomyopathies | 7 |
| Heart Valve Diseases | 7 |
Trials
Showing 76 to 79 of 79. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.